Several composite markers have been proposed for risk assessment in chronic obstructive pulmonary disease (COPD). However, choice of parameters and score complexity restrict clinical applicability. Our aim was to provide and validate a simplified COPD risk index independent of lung function.The PROMISE study (n=530) was used to develop a novel prognostic index. Index performance was assessed regarding 2-year COPD-related mortality and all-cause mortality. External validity was tested in stable and exacerbated COPD patients in the ProCOLD, COCOMICS and COMIC cohorts (total n=2988).Using a mixed clinical and statistical approach, body mass index (B), severe acute exacerbations of COPD frequency (AE), modified Medical Research Council dyspnoea severity (D) and copeptin (C) were identified as the most suitable simplified marker combination. 0, 1 or 2 points were assigned to each parameter and totalled to B-AE-D or B-AE-D-C. It was observed that B-AE-D and B-AE-D-C were at least as good as BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity), ADO (age, dyspnoea, airflow obstruction) and DOSE (dyspnoea, obstruction, smoking, exacerbation) indices for predicting 2-year all-cause mortality (c-statistic: 0.74, 0.77, 0.69, 0.72 and 0.63, respectively; Hosmer-Lemeshow test all p>0.05). Both indices were COPD specific (c-statistic for predicting COPD-related 2-year mortality: 0.87 and 0.89, respectively). External validation of B-AE-D was performed in COCOMICS and COMIC (c-statistic for 1-year all-cause mortality: 0.68 and 0.74; c-statistic for 2-year all-cause mortality: 0.65 and 0.67; Hosmer-Lemeshow test all p>0.05).The B-AE-D index, plus copeptin if available, allows a simple and accurate assessment of COPD-related risk.

Prognostic assessment in COPD without lung function : the B-AE-D indices / L. Boeck, J.B. Soriano, M. Brusse-Keizer, F. Blasi, K. Kostikas, W. Boersma, B. Milenkovic, R. Louis, A. Lacoma, R. Djamin, J. Aerts, A. Torres, G. Rohde, T. Welte, P. Martinez-Camblor, J. Rakic, A. Scherr, M. Koller, J. van der Palen, J.M. Marin, I. Alfageme, P. Almagro, C. Casanova, C. Esteban, J.J. Soler-Cataluña, J.P. de-Torres, M. Miravitlles, B.R. Celli, M. Tamm, D. Stolz. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - 47:6(2016 Jun), pp. 1635-1644.

Prognostic assessment in COPD without lung function : the B-AE-D indices

F. Blasi;
2016

Abstract

Several composite markers have been proposed for risk assessment in chronic obstructive pulmonary disease (COPD). However, choice of parameters and score complexity restrict clinical applicability. Our aim was to provide and validate a simplified COPD risk index independent of lung function.The PROMISE study (n=530) was used to develop a novel prognostic index. Index performance was assessed regarding 2-year COPD-related mortality and all-cause mortality. External validity was tested in stable and exacerbated COPD patients in the ProCOLD, COCOMICS and COMIC cohorts (total n=2988).Using a mixed clinical and statistical approach, body mass index (B), severe acute exacerbations of COPD frequency (AE), modified Medical Research Council dyspnoea severity (D) and copeptin (C) were identified as the most suitable simplified marker combination. 0, 1 or 2 points were assigned to each parameter and totalled to B-AE-D or B-AE-D-C. It was observed that B-AE-D and B-AE-D-C were at least as good as BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity), ADO (age, dyspnoea, airflow obstruction) and DOSE (dyspnoea, obstruction, smoking, exacerbation) indices for predicting 2-year all-cause mortality (c-statistic: 0.74, 0.77, 0.69, 0.72 and 0.63, respectively; Hosmer-Lemeshow test all p>0.05). Both indices were COPD specific (c-statistic for predicting COPD-related 2-year mortality: 0.87 and 0.89, respectively). External validation of B-AE-D was performed in COCOMICS and COMIC (c-statistic for 1-year all-cause mortality: 0.68 and 0.74; c-statistic for 2-year all-cause mortality: 0.65 and 0.67; Hosmer-Lemeshow test all p>0.05).The B-AE-D index, plus copeptin if available, allows a simple and accurate assessment of COPD-related risk.
English
Settore MED/10 - Malattie dell'Apparato Respiratorio
Articolo
Esperti anonimi
Ricerca di base
Pubblicazione scientifica
giu-2016
47
6
1635
1644
10
Pubblicato
Periodico con rilevanza internazionale
crossref
pubmed
Aderisco
info:eu-repo/semantics/article
Prognostic assessment in COPD without lung function : the B-AE-D indices / L. Boeck, J.B. Soriano, M. Brusse-Keizer, F. Blasi, K. Kostikas, W. Boersma, B. Milenkovic, R. Louis, A. Lacoma, R. Djamin, J. Aerts, A. Torres, G. Rohde, T. Welte, P. Martinez-Camblor, J. Rakic, A. Scherr, M. Koller, J. van der Palen, J.M. Marin, I. Alfageme, P. Almagro, C. Casanova, C. Esteban, J.J. Soler-Cataluña, J.P. de-Torres, M. Miravitlles, B.R. Celli, M. Tamm, D. Stolz. - In: EUROPEAN RESPIRATORY JOURNAL. - ISSN 0903-1936. - 47:6(2016 Jun), pp. 1635-1644.
reserved
Prodotti della ricerca::01 - Articolo su periodico
30
262
Article (author)
si
L. Boeck, J.B. Soriano, M. Brusse-Keizer, F. Blasi, K. Kostikas, W. Boersma, B. Milenkovic, R. Louis, A. Lacoma, R. Djamin, J. Aerts, A. Torres, G. Rohde, T. Welte, P. Martinez-Camblor, J. Rakic, A. Scherr, M. Koller, J. van der Palen, J.M. Marin, I. Alfageme, P. Almagro, C. Casanova, C. Esteban, J.J. Soler-Cataluña, J.P. de-Torres, M. Miravitlles, B.R. Celli, M. Tamm, D. Stolz
File in questo prodotto:
File Dimensione Formato  
prognostic assessment in copd without lung function the BAED indices ERJ 2016.pdf

accesso riservato

Descrizione: articolo principale
Tipologia: Publisher's version/PDF
Dimensione 341.35 kB
Formato Adobe PDF
341.35 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/392257
Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 33
social impact